blank LMU Munich Faculty for Chemistry and Pharmacy

ERC Project

Under the ERC Starting Grant ERC-2014-StG – 637830 "Novel Asthma Therapy" we are developing dry powder platform technologies for pulmonary delivery of siRNA for targeting activated T cells in the lung.

Our project has a clear potential of advancing pulmonary nanomedicine as novel asthma therapy.

Project-related publications: